rubocord cream 0.05%
rafarm a.e.b.e. ΚΟΡΙΝΘΟΥ 12, 15451 Ν. ΨΥΧΙΚΟ 6776550, 6747086 - clobetasol propionate - cream (ΚΡΕΜΑ) - 0.05% - clobetasol propionate 0,5mg - clobetasol
fodier cream 0.1% w/w
verisfield ΜΟΝΟΠΡΟΣΩΠΗ Α.Ε. Δ.Τ. verisfield Βύρωνος 8 & Γυθείου, Χαλάνδρι 152 31 210.7475196 - methylprednisolone aceponate - cream (ΚΡΕΜΑ) - 0.1% w/w - methylprednisolone aceponate 1mg - methylprednisolone aceponate
elocon 0.1% cream
n.v. organon (0000007178) kloosterstraat 6, oss, 5349 ab - mometasone furoate - cream - 0.1% - mometasone furoate (8000001488) 1mg - mometasone
movesan 0.1% w/w cream
iasis pharmaceuticals hellas sa (0000007836) 137 filis ave., kamatero, athens, 134 51 - mometasone furoate - cream - 0.1% w/w - mometasone furoate (8000001488) 1mg - mometasone
movesan 0.1% w/v cutaneous solution
iasis pharmaceuticals hellas sa (0000007836) 137 filis ave., kamatero, athens, 134 51 - mometasone furoate - cutaneous solution - 0.1% w/v - mometasone furoate (8000001488) 1mg - mometasone
sensibio (20mg/1mg)/g cream
iasis pharmaceuticals hellas sa (0000007836) 137 filis ave., kamatero, athens, 134 51 - fusidic acid; betamethasone valerate - cream - (20mg/1mg)/g - fusidic acid (8000002385) 20mg; betamethasone valerate (0002152445) 1,22mg - betamethasone and antibiotics
fodier 0.1%w/w cream
verisfield single member s.a. (0000003541) vironos 8 str., halandri, athens, 15231 - methylprednisolone aceponate - cream - 0.1%w/w - methylprednisolone aceponate (8000002206) 1mg
advantan 0.1% (w/w) cream
leo pharma a/s (0000003363) 55 industriparken, ballerup, 2750 - methylprednisolone aceponate - cream - 0.1% (w/w) - methylprednisolone aceponate (8000002206) 1mg
eylea
bayer ag - aflibercept - wet macular degeneration; macular edema; diabetes complications - Οφθαλμολογικά - eylea ενδείκνυται για ενήλικες για τη θεραπεία των:νεοαγγειακής (υγρής μορφής) ηλικιακής εκφύλισης της ωχράς κηλίδας (amd);όρασης λόγω οιδήματος της ωχράς κηλίδας δευτερεύουσα σε απόφραξη φλέβας του αμφιβληστροειδούς (υποκατάστημα rvo ή κεντρική rvo);όρασης λόγω διαβητικού οιδήματος της ωχράς κηλίδας (dme);όρασης λόγω μυωπική χοριοειδική νεοαγγείωση (μυωπική cnv).
yesafili
viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - Οφθαλμολογικά - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.